It was recently demonstrated in a genetically engineered mouse model that constitutive NF-κB activation, by Kras through AP-1-induced overexpression of interleukin-1α (IL-1α), is required for the development of pancreatic cancer [11]. Here, NFKB1 is linked to pancreatic neoplasm.